[Therapy of lupus-nephritis using corticosteroids and immunosuppressive agents].
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use*; D000974:Antibodies, Antinuclear / Q000032:analysis; D001379:Azathioprine / Q000008:administration & dosage / Q000627:therapeutic use; D001609:Beta-Globulins / Q000032:analysis; D002699:Chlorambucil / Q000627:therapeutic use; D003520:Cyclophosphamide / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005860:Germany, West; D005921:Glomerulonephritis / Q000473:pathology; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D008180:Lupus Erythematosus, Systemic / Q000150:complications / Q000188:drug therapy* / Q000401:mortality / Q000473:pathology; D008727:Methotrexate / Q000627:therapeutic use; D009393:Nephritis / Q000188:drug therapy* / Q000209:etiology; D012008:Recurrence
D000305:Adrenal Cortex Hormones; D000974:Antibodies, Antinuclear; D001609:Beta-Globulins; D007166:Immunosuppressive Agents; D002699:Chlorambucil; D003520:Cyclophosphamide; D001379:Azathioprine; D008727:Methotrexate
Zur Therapie der Lupus-Nephritis mit Corticosteroiden und Immunsuppressiva